23 matches for your search in the start-up spotlight
rss
Infex and Justus-Liebig-University Giessen awarded £1 million grant from PACE
18-Feb-2025
Infex Therapeutics, a leading anti-infectives specialist, announces that in collaboration with Justus-Liebig-University Giessen (“JLU”), Germany it has been awarded a £1 million grant from PACE (Pathways to Antimicrobial Clinical Efficacy), to develop a first-in-class BamA inhibitor targeting ...
Her start-up Baxiva is developing a vaccine that makes bacteria visible to the immune system
03-Feb-2025
Every second woman and every eighth man suffer from urinary tract infections. These are painful and can recur with serious health consequences. Pioneer Fellow Giorgia Greter has a solution. Giorgia Greter could have been sitting in one of these minimalist, but elegant offices of a venture capital ...
"Bacterial infections are likely to surpass cancer and heart disease as a number one cause of human deaths in the future..."
05-Sep-2024
Amferia, a Swedish medtech company focused on developing innovative antimicrobial healthcare solutions, announces the successful closure of a 1.2-million-euro investment round. The round was over prescribed and spearheaded by existing owners and new investors. The funding will support the ...
Innovations and expertise for the food tech industry
29-Jul-2024
On September 3, 2024, the New Food Conference will once again bring together the international alternative protein industry in Berlin - established manufacturers and innovative start-ups, forward-thinking investors and future-oriented suppliers, application-oriented scientists and committed ...
Novel preventive agent against multi-resistant bacteria to combat their colonization in the nose
01-Jul-2024
In recent years, HYpharm has worked with university partners and with the support of the German Center for Infection Research (DZIF) to further develop and investigate the active ingredient HY-133. HY-133 is a novel protein that originally comes from bacteriophages - viruses that only infect ...
OLIPI Receives €1.8 Million Seed Funding for Further Development of CO2-Neutral Climate Oil
01-Feb-2024
The conclusion of the Seed funding round marks a significant success for the Hamburg-based deep-tech startup COLIPI GmbH as it embarks on the year 2024. Investors include the High-Tech Gründerfonds (HTGF), the Innovationsstarter Fonds Hamburg (IFH), Nidobirds Ventures GmbH, and Stefan De Loecker. ...
New technology uses living bacteria to fight cancer
28-Nov-2023
The biotech company T3 Pharmaceuticals, a spin-off from the University of Basel, is being acquired by the German pharmaceutical company Boehringer Ingelheim. T3 Pharma has developed a novel technology that uses live bacteria to deliver therapeutic proteins to cancer cells and the tumor ...
Spin-out from the Universities of Glasgow and Oxford
21-Nov-2023
Glox Therapeutics, a company pioneering the development of precision antibiotic therapies based on naturally occurring bacteriocins, announced it has raised £4.3M in seed funding to develop effective targeted therapeutics against antibiotic-resistant Gram-negative bacteria. The Company will use ...
A coating protects nitrogen-fixing bacteria: Start-up to commercialise coated bacteria for large-scale use in regenerative agriculture
21-Nov-2023
Production of chemical fertilizers accounts for about 1.5 percent of the world’s greenhouse gas emissions. MIT chemists hope to help reduce that carbon footprint by replacing some chemical fertilizer with a more sustainable source — bacteria. Bacteria that can convert nitrogen gas to ammonia ...
Smartbax nominated for Falling Walls award
06-Nov-2023
It all began with basic research: While conducting laboratory experiments, a team at the Technical University of Munich (TUM) came across an active agent against multidrug-resistant bacteria with a fundamental difference to antibiotics developed to date. The researchers have since established a ...
